Herpes Simplex Virus (HSV) Treatment Market to be Dominated by Topical type through 2028
Increasing prevalence of HSV infection is expected to drive the
growth of Global Herpes Simplex Virus (HSV) Treatment Market in the forecast
period, 2024-2028.
According to TechSci Research report, “Herpes Simplex Virus (HSV) Treatment Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028,”
the Global Herpes Simplex Virus (HSV)
Treatment Market is anticipated to grow at an impressive rate in the forecast
period, 2024-2028. This can be ascribed to the increase in infectious
disease outbreaks along with rising cases of hospital-acquired infection among
the population across the globe. Additionally, growing demand for acyclovir
across the globe and increasing demand for effective treatment for rare
diseases, especially in the developed countries in North America and Europe, is
expected to create lucrative opportunities for market growth in coming years. Besides,
increasing transmission of herpes and a surge in the usage of unhygienic
practices in underdeveloped and developing countries is further expected to support
the market growth.
However, side
effects related to the use of drugs and ignorance of treatment for herpes are
likely to slow down the growth of the Global Herpes Simplex Virus (HSV)
Treatment Market in the forecast period. Similarly, the lack of reimbursement
procedures for HSV treatment and the high cost of treatment may hamper the Herpes Simplex Virus (HSV) Treatment market growth
during the forecast period. Also, a lack of awareness about the new therapy for
the treatment in emerging countries can further restrict the growth of the
Global Herpes Simplex Virus (HSV) Treatment Market.
Browse over XX market data Figures
spread through XX
Pages and an in-depth TOC on "Herpes Simplex Virus (HSV) Treatment Market"
The Global Herpes Simplex Virus (HSV)
Treatment Market can be segmented by virus type, by treatment, by route of
administration, by distribution channel, and by region.
Based on route of
administration, the Global Herpes Simplex Virus (HSV) Treatment Market can be segmented
into Oral,
Intravenous, Topical. The topical segment dominated
the market in 2022 and is expected to continue maintaining its dominance
throughout the forecast period. This can be ascribed to increasing demand for
consumer-friendly products which makes them feasible and highly accepted by a wide
range of consumers.
Based on distribution channel, the market can
be segmented into Hospital
Pharmacy, Retail Pharmacy, Online Pharmacy.
The hospital pharmacies segment is expected to dominate during the forecast
period on account of the increasing the prevalence of chronic diseases and
continuous flow of patients in the hospitals.
Major companies operating in Global
Herpes Simplex Virus (HSV) Treatment Market are:
- Novartis International AG
- GlaxoSmithKline, plc.
- Sanofi SA
- Mylan N.V.
- Emcure Pharmaceuticals Ltd.
- Glenmark Pharmaceuticals Inc.
- Fresenius Kabi AG
- Apotex Inc.
- Viatris Inc.
- Teva Pharmaceuticals
Industries Ltd
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“North America is expected to dominate in the Global Herpes Simplex Virus (HSV)
Treatment Market on account due to the increasing demand for branded herpes
drugs along with the increasing launch of generics across the region.
Furthermore, increasing development of healthcare expenditure and growing
favorable reimbursement policies for HSV treatment are further contributing to the
demand for herpes simplex virus treatment. Besides, the availability of skilled
professionals and early adoption of advanced treatments for herpes treatment in
the region is further expected to create lucrative opportunities for market
growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Herpes Simplex Virus
(HSV) Treatment Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Virus Type (HSV-1 v/s HSV-2), By Treatment
(Drugs v/s Vaccines), By Route of Administration (Oral, Intravenous, Topical),
By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region,” has evaluated
the future growth potential of Global Herpes Simplex Virus (HSV) Treatment Market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Herpes Simplex Virus (HSV) Treatment
Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com